SFX by Ex Libris Inc.

Title:	Subtypes of medulloblastoma have distinct developmental origins
Source:	Nature [0028-0836] Gibson, P yr:2010

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Scotting, P. "Opinion - Childhood solid tumours: a developmental disorder." Nature Reviews. Cancer 5.6 (2005): 481-488.
description	2.	Ellison, David W. "Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups." Acta neuropathologica 121.3 (2011): 381-96.
description	3.	Ellison, David W W. "The origins of medulloblastoma subtypes." Annual review of pathology 3.161324238 (2008): 341-65.
description	4.	Li, Xiao-Nan N. "Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC." Molecular cancer therapeutics 4.12 (2006): 1912-1922.
description	5.	Lindsey, Janet C C. "Epigenetic events in medulloblastoma development." Neurosurgical focus 19.5 (2005): 1-.
description	6.	Brodeur, Garrett M M. "Neuroblastoma: biological insights into a clinical enigma." Nature reviews. Cancer 3.3 (2003): 203-216.
description	7.	Stokland, T. "A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)." Neuro-oncology 12.12 (2010): 1257-1268.
description	8.	Ellison, David W. "Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables." Journal of clinical oncology 29.11 (2010): 1400-1407.
description	9.	Pomeroy, Scott L L. "Prediction of central nervous system embryonal tumour outcome based on gene expression." Nature 415.6870 (2002): 436-442.
description	10.	Gogtay, N. "Dynamic mapping of human cortical development during childhood through early adulthood." Proceedings of the National Academy of Sciences of the United States of America 101.21 (2004): 8174-9.
description	11.	Roses, Allen D D. "Pharmacogenetics and drug development: the path to safer and more effective drugs." Nature reviews. Genetics 5.9 (2004): 645-56.
description	12.	Al-Halabi H, Hani H. "Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma." Acta neuropathologica 121.2 (2010): 229-239.
description	13.	Memili, E. "Synchronization of goat fibroblast cells at quiescent stage and determination of their transition from G0 to G1 by detection of cyclin D1 mRNA." Cloning and stem cells 6.2 (2004): 58-66.
description	14.	Eberhart, Charles G G. "Anaplasia and grading in medulloblastomas." Brain pathology 13.3 (2003): 376-85.
description	15.	Kool, M. "Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features." PloS one 3.8 (2008).
description	16.	Navarro, A. "MicroRNA expression profiling in classical Hodgkin lymphoma." Blood 111.5 (2008): 2825-2832.
description	17.	Kaspers, G J L J. "Implementation of a Multi-Institutional Diffuse Intrinsic Pontine Glioma Autopsy Protocol and Characterization of a Primary Cell Culture." Neuropathology & applied neurobiology 39.4 (2012): 426-436.
description	18.	Fouse, Shaun D. "Epigenetics of neurological cancers." Future Oncology 5.10 (2009): 1615-1629.
description	19.	Nazarali, A. "Ascorbic Acid Reverses Valproic Acid-Induced Inhibition of Hoxa2 and Maintains Glutathione Homeostasis in Mouse Embryos in Culture." Cellular and molecular neurobiology 30.1 (2009): 137-148.
description	20.	Agathanggelou, A. "Role of the Ras-association domain family 1 tumor suppressor gene in human cancers." Cancer research 65.9 (2005): 3497-508.